Biotechnology
ACST
2.87
price down icon6.51%   -0.20
 

Acasti Pharma Inc (ACST)
loading
Overview News Price History Discussions Forecast Stock Split
Acasti Pharma Inc stock is currently priced at $2.87, with a 24-hour trading volume of 19,803. It has seen a -6.51% decreased in the last 24 hours and a -15.59% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $3.10 pivot point. If it approaches the $2.92 support level, significant changes may occur.

Acasti Pharma Inc Stock (ACST) Financials Data

Acasti Pharma Inc (ACST) Net Income 2024

ACST net income (TTM) was -$40.27 million for the quarter ending September 30, 2023, a -135.03% decrease year-over-year.
loading

Acasti Pharma Inc (ACST) Cash Flow 2024

ACST recorded a free cash flow (TTM) of -$15.40 million for the quarter ending September 30, 2023, a +7.24% increase year-over-year.
loading

Acasti Pharma Inc (ACST) Earnings per Share 2024

ACST earnings per share (TTM) was -$5.0517 for the quarter ending September 30, 2023, a -182.39% decline year-over-year.
loading

Acasti Pharma Inc Stock (ACST) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Olds Donald
Director
Aug 31 '23
Buy
2.05
381
781
381

Acasti Pharma Inc Stock (ACST) Latest News

Acasti Announces Poster Detailing its GTX-104 STRIVE-ON Trial

pulisher
GlobeNewswire Inc.

Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

pulisher
Benzinga

Acasti to Participate in Upcoming San Francisco Investor Conferences in January 2024

pulisher
GlobeNewswire Inc.

About Acasti Pharma Inc

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.

KEY STATS

Previous Close:
$3.07
Market Cap:
$26.98M
24h Volume:
19,803
1D Range:
$2.87 - $3.08
52W Range:
$0.43 - $3.7594
Primary Exchange:

COMPANY PROFILE

NameNameAcasti Pharma Inc
sectorSectorHealthcare (1201)
industryIndustryBiotechnology (691)
webWebacastipharma.com
phonePhone450 687 2262
twitter-icon Twitter @AcastiPharma
chart-line-icon Latest SEC Filings
twitter-icon ACST's Discussions on Twitter
location3009 boulevard de la Concorde East, Suite 102, Laval, QC, Canada (H7E 2B5)

UPGRADES & DOWNGRADES

Downgrade Oppenheimer: Outperform → Perform Sep-01-20
Upgrade B. Riley FBR: Neutral → Buy Jul-06-20
Downgrade B. Riley FBR: Buy → Neutral Jan-13-20
Initiated B. Riley FBR: Buy Aug-29-19
Initiated Oppenheimer: Outperform Jul-18-19
Initiated H.C. Wainwright: Buy Jun-26-19
More Upgrades & Downgrades

Similar to ACST

biotechnology BGNE
$129.52
price down icon 1.85%
biotechnology BMRN
$88.63
price down icon 1.60%
biotechnology ALNY
$144.41
price down icon 0.52%
biotechnology GMAB
$28.70
price up icon 1.31%
biotechnology BNTX
$86.81
price up icon 0.74%
biotechnology ARGX
$360.23
price up icon 0.51%
Open in Yahoo | Open in Google | Open in Finviz
Cap:     |  Volume (24h):